Activation of Stat5 by many cytokines implies that it cannot alone insure the speci®city of the regulation of its target genes. We have evidenced a physical and functional interaction between members of two unrelated transcription factor families, Ets-1, Ets-2 and Stat5, which could contribute to the proliferative response to interleukin 2. Competition with GAS-and EBS-speci®c oligonucleotides and immunoassays with a set of antiStat and anti-Ets families revealed that the IL-2-induced Stat5-Ets complex recognizes several GAS motifs identi®ed as target sites for activated Stat5 dimers. Coimmunoprecipitation experiments evidenced that a Stat5/Ets-1/2 complex is formed in vivo in absence of DNA. GST-pull down experiments demonstrated that the C-terminal domain of Ets-1 is sucient for this interaction in vitro. Cotransfection experiments in Kit225 T cells resulted in cooperative transcriptional activity between both transcription factors in response to a combination of IL-2, PMA and ionomycin. A Stat5-Ets protein complex was the major inducible DNAbinding complex bound to the human IL-2rE GASd/ EBSd motif in long-term proliferating normal human T cells activated by CD2 and CD28. These results suggest that the inducible Stat5-Ets protein interaction plays a role in the regulation of gene expression in response to IL-2 in human T lymphocytes.
Introduction
Signal transducer and activators of transcription 5 (Stat5a and Stat5b) and Ets-1, and Ets-2, belong to two distinct groups of transcription factors, the Stat family and the Ets family. Both families play important roles in cell dierentiation and in immune responses induced by cytokines, and a wealth of evidences has demonstrated their key roles in oncogenesis (CatlettFalcone et al., 1999; Ghysdael and Boureux, 1997) . Stat proteins are transcription factors activated by tyrosine phosphorylation in the cytoplasm or in the vicinity of the cytoplasmic membrane prior to their translocation to the nucleus where they bind to DNA sequences, predominantly related to the gamma interferon (IFNg) activated site (GAS) (Darnell, Jr, 1997; Leonard and O'Shea, 1998) . Seven mammalian Stat genes have been cloned: Stat1, Stat2, Stat3, Stat4, Stat5a, Stat5b and Stat6. In contrast to Stat4 and Stat6 activation by a limited number of cytokines, Stat5a and Stat5b are activated by many cytokines, including prolactin (PRL), growth hormone, IFNg and interleukin-2 (IL-2). Speci®c gene activation by these cytokines cannot depend solely on Stat5 but likely involve association with other cell type and/or induction speci®c factors.
It is now well established that the lineage-speci®c and inducible expression of eukaryotic genes is controlled by assembly of multipartite complexes of transcription factors on regulatory regions composed of sequence-speci®c protein binding sites. In that respect, some Stat proteins bind to other transcription factors or coactivators to activate transcription (Bhattacharya et al., 1996; Look et al., 1995; Muhlethaler-Mottet et al., 1998; Qureshi et al., 1995; Schaefer et al., 1995; Shen and Stavnezer, 1998; Zhang et al., 1996) . More speci®cally, MGF/Stat5a has only been reported to form a complex with the glucocorticoid receptor (GR) on the b-casein promoter devoid of GR binding site (GRE) (Cella et al., 1998; StoÈ cklin et al., 1996) . However, Stat5 has not been shown to bind to any known transcription factors in the immune system.
The Ets gene family encodes a family of transcription factors involved in a variety of biological processes, including growth control, transformation, T cell activation and developmental programs (Anderson et al., 1999; Bassuk and Leiden, 1997; Ghysdael and Boureux, 1997) . Over 30 members belonging to this family share a highly conserved DNA binding domain and bind to distinct sites containing a core purine rich motif (EBS). Several Ets factors interact with other regulators of gene expression and cell cycle progression. Ets-1 binds various transcription factors, including Sp1 (Gegonne et al., 1993) , PEBP2a/AML-1 (Giese et al., 1995) , GHF-1/Pit-1 (Bradford et al., 1995) , MafB (Sieweke et al., 1996) , NF-kB, AP-1 (Thomas et al., 1997) , and USF-1 (Sieweke et al., 1998) . Despite its high degree of structural similarity with Ets-1, only one protein-protein interaction between Ets-2 and p300/CBP (Jayaraman et al., 1999) and two transcriptional cooperations with GATA3 (Blumenthal et al., 1999) or ATF/Jun family members (Cirillo et al., 1999) have been reported. Two Stat-Ets cooperations have been described. One established that PU.1/Spi-1 and Stat1 are required for IFN induced expression of the FcgRI receptor (Perez et al., 1994) , whereas the second suggested a functional cooperation between Stat5 and the lymphoid Ets factor Elf-1 (John et al., 1996; Serdobova et al., 1997) . The transcriptional synergies between both families required the presence of their respective cognate binding sites.
A positive regulatory region (PRRIII/IL-2rE) has been identi®ed as a target site for IL-2-activated Stat5a and Stat5b proteins both in human and mouse CD25/ IL-2Ra genes (John et al., 1996; Lecine et al., 1996; Soldaini et al., 1995) . Consistent with a role of both Stat5 proteins in the transcriptional activation of the CD25/IL-2Ra gene, expression of the inducible chain of IL-2 was not maintained on lymphocytes of Stat5a/ b-de®cient mice in presence of IL-2 (Moriggl et al., 1999) . PRRIII is a composite region composed of both consensus and non-consensus GAS motifs (GASd and GASp), two distinct Ets binding sites (EBSd and EBSp) and one GATA motif. IL-2 induced formation of two GAS-speci®c protein complexes revealed by a GASd/EBSd probe. Both inducible complexes contained Stat5 but their dierent migration was not elucidated. We now report that, in tumoral Kit225 T cells and in human peripheral blood T lymphocytes, the GASd/EBSd regulatory element was mainly bound constitutively by GAPBa/b and that Ets-1 and Ets-2 proteins were associated with Stat5 in the slower migrating IL-2-inducible protein-DNA complex. IL-2 induced a physical association of Stat5b with either Ets-1 or Ets-2 in absence of DNA and transient cotransfection experiments revealed a transcriptional cooperation between these two unrelated transcription factor families.
Results
IL-2 induces a GAS-specific protein-DNA binding complex containing Stat5b, Ets-1 and Ets-2 IL-2 induces formation of two distinct GAS-speci®c protein-DNA complexes on the GASd/EBSd regulatory element within PRRIII enhancer of IL-2Ra gene (Lecine et al., 1996) . Competition with an unlabeled GASd/EBSd oligonucleotide abolished the constitutive complex (C1) and the two IL-2-induced complexes (C2 and C3) revealed by EMSAs (Figure 1a , compare lanes 1, 2 and 3). In contrast, a mutant GASd/EBSd oligonucleotide with a disrupted GAS had no eect on C2 and C3 but signi®cantly reduced C1 (Table 1 and Figure 1a , lane 4). The oligonucleotide containing a disrupted EBS motif fully abolished both inducible complexes and reinforced the constitutive C1 complex (Figure 1a , lane 5) whereas an oligonucleotide containing both disrupted motifs had no eect ( Figure 1a , lane 6). EBSa, an high anity Ets binding site ( and Table 1 ), abrogated C1 without aecting the inducible C2 and C3 complexes whereas EBSz, its mutated counterpart, had no eect (Figure 1a , compare lane 2 with lanes 7 and 8). IL-2 induced C2 and C3 complexes are speci®c for the GAS consensus in the human GASd/EBSd element while the constitutive C1 complex depends on the EBS motif.
Immunoassays revealed that C2 and C3 complexes contained Stat5b proteins but their dierent migration was not explained and could be due either to the degree of Stat5 protein multimerization or to the presence of additional polypeptides. The EBS element is absent in site I, the murine counterpart of GASd/ EBSd, although the IL-2 responsive enhancer is highly conserved in both species (Bucher et al., 1997) . To characterize the composition of the IL-2-inducible complexes, EMSAs were performed with three probes corresponding to human GASd/EBSd, FcgRI GAS and mouse site I (Table 1) . In contrast to previous reports (John et al., 1999; Meyer et al., 1997) , the three probes revealed both complexes in human T cell nuclear extracts, evidencing that they were not a singularity of the human GASd/EBSd element ( Figure  1b ). Supershift and inhibition of binding assays were performed with speci®c antisera. Anti-Sta5b serum supershifted C2 and C3 complexes (Figure 2a , lane 3), con®rming that both complexes contained Stat5b. Figure 1 Two GAS-speci®c protein-DNA complexes are induced by IL-2 in Kit225 leukemic T cells. (a) EMSA competition experiments were performed using the GASd/EBSd probe and Kit225 nuclear extracts IL-2 deprived (lane 1) or IL-2 stimulated (lanes 2 ± 6) without (lanes 1 and 2) or in the presence of a 1006excess of unlabeled competitors: wild-type GASd/EBSd (lane 3, wt); GASd/EBSd mutated in GASd site (lane 4, mGASd); GASd/EBSd mutated in EBSd site (lane 5, mEBSd); GASd/EBSd mutated on both site (lane 6, mGASd/mEBSd); an high anity Ets-binding site (lane 7, EBSa,) and its mutated form (lane 8, EBSz) (Rabault and Ghysdael, 1994) . (b) EMSAs were performed with human GASd/EBSd (lanes 1 and 2), murine Site I (lanes 3 and 4), or human FcgRI-GAS (lanes 5 and 6) probes and nuclear extracts from Kit225 T cells IL-2 starved (lanes 1, 3 and 5) or IL-2 stimulated during 1 h (lanes 2, 4 and 6) Inhibition of binding by antisera speci®c for Ets-1 and Ets-2 revealed that the slower migrating inducible C3 complex contained both Ets proteins (Figure 2a , lanes 4, 5 and 6) whereas faster migrating C2 was unaected. Antisera against other members of the Ets family (Elf-1, GABPa/b, Fli-1 and Tel) failed to aect C3 complex (data not shown). Similar results were obtained using a FcgRI probe (Figure 2b ), a well-de®ned GAS motif devoid of any functional EBS (Beadling et al., 1994) .
The IL-2-induced proteins were further identi®ed by DNA anity puri®cation using a GASd/EBSd biotinylated probe and Kit225 cell extracts (Figure 2c ). Western blotting analysis con®rmed that IL-2 induced not only Stat5b but also Ets-1 or Ets-2 binding ( Figure  2c , compare lanes 1 and 2). The doublet observed with anti-Stat5b was likely due to the level of serine phosphorylation of this protein . The same assay using biotinylated EBSa revealed the constitutive binding of Ets-1 or Ets-2 proteins but did not reveal Stat5b. Furthermore, IL-2 induced a weak but reproducible increase of Ets protein binding (Figure 2c, lanes 3 and 4) .
Taken together, these results strongly supported that Ets-1, Ets-2 and Stat5b form a functional GAS-speci®c DNA-binding complex in response to IL-2 in Kit225 T cells, which is not a peculiarity of the GASd/EBSd motif of the human CD25/IL-2Ra gene.
In vivo and in vitro interactions of Stat5b, Ets-1 and Ets-2 in response to IL-2
Identi®cation of an IL-2-induced Stat5-Ets DNA binding complex with several GAS probes prompted us to investigate whether these proteins might interact in absence of DNA. Unstimulated or IL-2-stimulated Kit225 cell extracts were immunoprecipitated with antiEts-1 and/or -Ets-2 sera and analysed by immunoblotting with an anti-Stat5b serum. Stat5b was coimmunoprecipitated with Ets-1 and Ets-2 in response to IL-2 ( Figure 3a , lanes 2, 4 and 6) but not by an anti-c-Rel (Figure 3a , lanes 7 and 8). The doublet suggested that Ets-1 and Ets-2 interact with both forms of Stat5 tyrosine phosphoprotein . To con®rm this interaction in absence of DNA, Ets-1 recombinant proteins were used in GST-pull down assays ( Figure 3b ). Full-length Ets-1 and an N-terminal truncated form, containing the Ets domain, eciently interacted with IL-2-activated Stat5b (Figure 3c ). These results demonstrated the formation of an IL-2 inducible protein complex associating Stat5b, Ets-1 and/or Ets-2 proteins in absence of their cognate DNA binding sites.
Cooperative transcriptional activation by Stat5b, Ets-1 and Ets-2
Identi®cation of an IL-2-induced Stat5-Ets complex suggested a transcriptional synergy between these transcription factors. To analyse this putative synergy and to avoid the complex interactions observed within the native IL-2rE (John et al., 1996 (John et al., , 1999 Meyer et al., 1997) , wild-type and mutant GASd/EBSd trimers were inserted upstream of HSV TK minimal promoter ( Figure 4a ). The design of these arti®cial targets was validated by the binding properties of WT and mutants GASd/EBSd motifs ( Figure 1a ). After transfection in Kit225 cells, IL-2 induced the wild-type GASd/EBSd construct ( Figure 4b ) whereas disruption of the GASd motif fully abrogated IL-2-induced CAT activity. EBSd disruption dramatically reduced the overall transcriptional activity without aecting the induction level and the double mutation completely abolished both constitutive and inducible activities.
Cotransfection assays evidenced that IL-2 alone was unable to trigger a cooperation between exogenous Stat5b, Ets-1 and Ets-2 (data not shown). In Jurkat T 
Sequences are in 5' to 3' orientation. GAS motifs are underlined and EBS motifs are doubly underlined. The mutated nucleotides are in boldface IL2-induced Stat5-Ets interactions in T cells P Rameil et al cells, ecient transactivation of a GM-CSF or IL-5 promoter reporter construct by Ets-1 and Ets-2 required a combined stimulation with PMA and ionomycin, that mimics engagement of the T cell receptor (Blumenthal et al., 1999; Thomas et al., 1997) . We postulated that endogenous transduction pathways in response to IL-2 alone did not eciently activate overexpressed Ets-1 and Ets-2. Accordingly, the transcriptional activity of a pentameric EBS reporter gene construct transfected in Kit225 cells was slightly activated by IL-2 whereas addition of PMA plus ionomycin resulted in a strong induction dependent of a bona ®de EBS ( Figure 5a ). Therefore, further assays were performed in Kit225 T cells activated by a combination of IL-2, PMA and ionomycin. Transfection of wild-type GASd/EBSd trimeric construct with Stat5b, Ets-1 and Ets-2 resulted in a 27-fold induction in response to a triple IL-2, PMA (Figure 5c ). To highlight eects of either factor addition, data in Figure 5d represent the ratio of the CAT activity of the double or the triple cotransfection relative to the averaged CAT activity observed with single cotransfections. Ets-1 and Ets-2 overexpression in the same recipient cells resulted in a minor increase not signi®cantly dierent from transactivation with either Ets protein (Figure 5b and d) and there was no signi®cant dierence with either Ets-1 or Ets-2 cotransfected with Stat5b (data not shown). In contrast, cotransfection of Stat5b, Ets-1 and Ets-2 resulted in a 3.5-fold increase relative to the transcriptional activity observed with single cotransfection (i.e. 30 ± 40-fold increase in comparison to the empty reporter gene vector). Requirement of a bona ®de Figure  5d ). This residual transcriptional activity is most probably due to direct binding of Ets proteins to the preserved EBSd motif in agreement with its binding activity revealed by EMSAs. In comparison, the synergistic eect was conserved with the trimeric construct containing a disrupted EBSd site. As expected, the double mutation fully abolished cooperation between Stat and Ets.
Taken together, these results demonstrated a cooperative transactivation of GAS regulatory elements by Stat5b, Ets-1 and Ets-2 proteins.
IL-2-dependent mitogenic stimulation of human primary T cells induces a major protein-DNA complex containing Stat5a, Stat5b, Ets-1 and/or Ets-2
To investigate whether the IL2-induced Stat-Ets complex identi®ed in the Kit225 tumoral T cell line represented a component of the physiological IL-2 response, EMSAs were performed with nuclear extracts from human primary T cells activated via CD2+CD28. This potent costimulation triggers an IL-2-dependent proliferation of human primary T cells, mimicking the antigen-dependent T lymphocyte activation (Olive et al., 1994) . Time-course analysis with the GASd/EBSd probe revealed two major modi®cations ( Figure 6a ): (1) a strong constitutive fast migrating protein-DNA complex, C1p, dramatically reduced 30 min after stimulation (Figure 6a , compare lanes 1 and 2 ± 8); (2) a major inducible slower migrating complex, C2p after 4 ± 6 days ( Figure 6a , lanes 5 and 6) that was strongly reduced after 8 days (Figure 6a, lanes  7 and 8) . Other minor modi®cations were not reproducibly observed and not further characterized.
Immunoassays with antisera against several Ets proteins revealed that the C1p constitutive complex was composed mostly, if not exclusively, of GABPa and GABPb (Figure 7a) . A similar assay with Kit225 nuclear extracts revealed that, beside a previously characterized minor Elf-1 component (Lecine et al., 1996) , the C1 complex was also mainly composed of GABPa/b (data not shown). Since IL-2 secretion by CD2+CD28-stimulated T lymphocytes peaked at day 4 ± 6 (Costello et al., 1993) , we focused on the DNAbinding speci®city and composition of the inducible C2p in T cells 6 days after stimulation. Competition experiments with wild-type, GAS and/or EBS disrupted oligonucleotides evidenced that C2p was speci®c for the GASd motif (Figure 6b ), as reported above for IL-2-induced C2/C3 complexes in the leukemic T cell model Kit225. Anti-Stat5, Ets-1 or Ets-2 sera alone partially supershifted C2p complex whereas their combination abolished its formation (Figure 7b , compare lanes 3 ± 5 with lane 6). An irrelevant antiSp1 did not aect C2p (Figure 7b, lane 7) . Further controls were performed with sera directed against other Stat family members (Stat3, Stat4 and Stat6) con®rming the composition of complex C2p ( Figure  7c ). Taken together, these results demonstrated that the major complex C2p induced by CD2+CD28 in human primary T lymphocytes is a GAS-speci®c macromolecular complex containing Stat5, Ets-1 and/or Ets-2 proteins.
Despite their near identical antigenic and DNAbinding speci®cities, the constitutive and inducible complexes revealed by EMSAs performed with nuclear extracts of tumoral Kit225 and primary T cells did not exhibit the same mobility (Figure 7d ). This discrepancy suggests that tumoral and primary T cell complexes either dier in the structural conformation and/or the stoichiometry of their various constituents, or contain one or more dierent partners. For example, we have already reported that Kit225 T cells lack Stat5a protein in contrast to primary T cells which express comparable amounts of Stat5a and Sta5b (Lecine et al., 1996) . However, further experiments aimed to identify the components of each complex are required to elucidate the unexpected dierences in the migration pattern.
Discussion
We have evidenced a physical and functional association between the Ets-1, Ets-2, and Stat5 transcription factors. These associations occur not only in human leukemic Kit225 T cells in response to IL-2 but also in human primary T lymphocytes activated in vitro by CD2+CD28 costimulation, a potent IL-2-dependent inducer of long-term proliferation, which mimics the physiological antigenic activation of human peripheral blood T lymphocytes (Olive et al., 1994) . Interactions between these two unrelated transcription families resulted in formation of a composite protein-DNA complex revealed by EMSA with GAS-speci®c oligonucleotidic probes derived from IL-2Ra and FcgRI genes, and in the cooperative transactivation of trimeric GASd/EBSd reporter gene constructs.
We previously reported that Elf-1 a lymphoid Ets family member can serve as a transcriptional repressor of IL-2rE/PRRIII In Kit225 leukemic T cells (Lecine et al., 1996) . Our conclusions were based upon transient overexpression of an Elf-1 expression vector in presence of IL-2 alone. In the light of our new observations, we wondered whether this ectopic factor might act so because of the absence of the additional stimulation of PMA and ionomycin. However, we failed to observe any signi®cant cooperation between Stat5 and Elf-1 in transient cotransfection in IL2+PMA+ionomycin-treated Kit225 T cells (data not shown). The dramatic decrease of the constitutive complex C1p observed in resting T lymphocytes stimulated by CD2+CD28 suggests that this Etsrelated protein-DNA complex plays a negative role in IL-2Ra gene expression regulation. The C1p complex was mostly composed of GABPa/b, an Ets-related heterotetramer (Brown and McKnight, 1992; Thompson et al., 1991) that could act as a repressor or as an activator depending on the promoter context (Genuario and Perry, 1996; Schaeer et al., 1998) . Altogether these observations suggest that GABP could play a role in primary T cells, yet to be con®rmed.
The identi®cation of the Stat5-Ets DNA binding complex with various GAS-speci®c oligonucleotidic probes derived from IL-2Ra and FcgRI genes, containing or not an identi®ed EBS consensus, demonstrated that this composite complex was not a peculiarity of the human GASd/EBSd motif. Two recent studies have underscored the requirement for Stat5 tetramerization mediated by the two PRRIII GAS motifs for ecient promoter recruitment and transcriptional activation (John et al., 1999; Meyer et al., 1997) . Although the experiments presented here were not designed to address the respective role of the two GAS elements present within human PRRIII, some of our results dier signi®cantly from those recently reported. In vivo genomic footprinting clearly evidenced an inducible occupancy solely within the GASd/EBSd site, whereas the GASp/GATA site was constitutively occupied (Lecine et al., 1996) . This argues against an IL-2 inducible cooperative binding on both sites but does not preclude their functional interaction. Moreover, we con®rmed our previous report (Lecine et al., 1996) and observed ecient binding of two GAS-speci®c complexes on monomeric GAS-speci®c motif using both tumoral and primary human T cell extracts, whereas John and collaborators (John et al., 1999) did not report any signi®cant Stat5 binding with a monomeric GASc probe (almost identical of our GASd/EBSd probe). We did not elucidate this discrepancy but we suspect some dierences in EMSA protocols. This interpretation is reinforced by the fact that the authors reported only a weak bona ®de Stat5 binding in IL-2-stimulated PBL but did not detect the faster migrating EBS-speci®c and slower Stat5-Ets composite complexes.
Presence of Stat5 in the C2p inducible complex is in line with one of its roles evidenced in mice defective for Stat5 expression (Feldman et al., 1997; Imada et al., 1998; Moriggl et al., 1999; Nakajima et al., 1997; Teglund et al., 1998; Udy et al., 1997) . The phenotype of peripheral T cells from Stat5a/b-de®cient mice, opposed to single knock-out, revealed a crucial and interchangeable role for these proteins in IL-2 signaling (Moriggl et al., 1999) . Mature T cells of these mice exhibited a dramatic decrease in proliferative response triggered by anti-CD3 and IL-2. Furthermore, the expression of CD25/IL-2Ra on lymphocytes from Stat5a/b-de®cient mice was not maintained in the presence of IL-2, consistent with a role for the Stat5 proteins in CD25 expression in CD4 + lymphocytes. In agreement with a role in IL-2-mediated lymphocyte survival (Zamorano et al., 1998) , the Stat5-Ets complex was predominant in long-term proliferating primary T cells. Ets-1 presence is consistent with its regulatory role in T cell proliferation and apoptosis (Muthusamy et al., 1995) , whereas Ets-2 does not appear essential for lymphoid cells (Yamamoto et al., 1998) . Ets-1 expression during activation of normal mature T cells is in agreement with the late appearance of the Stat5-Ets complex. Ets-1 mRNA is expressed at high levels in quiescent cells, eciently down regulated after activation and reinduced to the levels observed in resting cells 3 days after PMA+ionomycin stimulation (Bhat et al., 1989) .
Activation of resting T lymphocytes requires at least two signals: one provided by engagement of the T cell antigen receptor complex (TcR/CD3) with antigen associated with MHC and the second by costimulatory molecules, such as CD28 Ward, 1996) . In Kit225 T cells, transcriptional activity, but not formation, of Stat-Ets complex required a triple combination of stimuli (IL-2, PMA and ionomycin). These observations suggest integration between dierent T cell signaling pathways, mediated by the formation of Stat5 and Ets-1/2 protein complex in solution that can then form higher order oligomeric complexes on DNA. IL-2 activates Stat5 via activation of protein tyrosine kinases Jak1 and Jak3 associated with receptor components (Ihle et al., 1997; Lin and Leonard, 1997) whereas T cell activation results in calcium-dependent serine phosphorylation and activation of Ets-1/2 proteins (Bassuk and Leiden, 1997; Pognonec et al., 1988) . Several studies have placed Ets-1 and Ets-2 in the Ras/MAPK signaling pathway (Coer et al., 1994; Miyazaki and Taniguchi, 1996; Rabault et al., 1996; Yang et al., 1996) . Our GST-pull down assays evidenced that the C-terminal region of Ets-1, containing the Ets domain, can interact with IL-2-activated Stat5b. The reciprocal experiment performed with GST-Stat5 recombinant proteins failed to reveal either Ets-1 or Ets-2 (data not shown), suggesting that Stat-Ets interaction requires IL-2-induced Stat5 dimerization (Figure 8 ). Further experiments will determine whether activation of the dierent pathways required for Stat5-Ets complex formation and transactivation depends only on IL-2 engagement on its receptor, or could integrate CD3/TcR, CD28 and IL-2R signaling. Finally, the present report does not address the question of the IL-2 speci®city and it will be pertinent to determine whether such complexes might be activated by other cytokines.
The cross-talk of Stat with several Ets proteins highlights an additional mechanism of gene regulation, involving physical association of Stat5a/b with a family of structurally distinct transcription factors in the absence of their cognate DNA binding sites ( Figure  8 ). This molecular mechanism might synergize their individual biological activities and act in long-term maintenance of T cell proliferation and/or survival.
Materials and methods

Cell culture
The IL-2-dependent human T cell Kit225 (Hori et al., 1987) was maintained in RPMI 1650 with 10% fetal calf serum (FCS) containing 2 mM L-glutamine and 1 nM recombinant IL-2 (Chiron). The cells were arrested in a quiescent state by washing them twice in PBS, and culturing in RPMI 1650 10% FCS without IL-2 for 20 h (for transient transfection assays) and for 2 days (for EMSAs, anity puri®cation of DNA-binding proteins GST-pull down and immunoprecipitations). T cell puri®cation from human peripheral blood and activation were performed as described (Costello et al., 1993) .
Primary T cells were maintained in RPMI 1650 10% FCS. Stimulations were performed with the following monoclonal antibodies (mAbs) used in combination at saturating concentrations. Anti-CD2 mAb 39C1.5 (rat IgG 2a ) and 6F10.3 (mouse IgG 1 ) were used as puri®ed mAbs at 10 mg/ ml each. Anti-CD28 248 (mouse IgM) was obtained from Dr A Moretta (Cancer Institute, Genova, Italy) and was used as ascitic¯uid (1/200 dilution). T cell activation was controlled by proliferation assays and CD25/IL-2Ra expression.
EMSA, affinity purification of DNA-binding protein, GST-pull down, immunoprecipitation and immunoblotting Nuclear extracts (Costello et al., 1993) and whole cell extracts (Lecine et al., 1996) of Kit225 and primary T cells were prepared as described. Kit225 cells were IL-2-starved for 2 days and stimulated by IL-2 during 1 h. Synthetic oligonucleotidic probes were labeled with g-32 P ATP. Name, sequence and origin of oligonucleotides used in EMSAs are indicated in Table 1 . Binding reactions, gel separation and detection were performed as described (Lecine et al., 1996) using 4 mg of nuclear extract. For competition experiments, unlabeled double-stranded oligonucleotides were pre-incubated with cell extracts for 10 min at RT prior to addition of the probe. Immunoassays were performed by incubating the binding reactions 30 min at 48C with antisera directed against Ets1/2 (#8), Fli-1 (#61), Tel (#69), Ets-1 (#49), Ets-2 (#36) (Bailly et al., 1994; Pognonec et al., 1988) , GABPa, GABPb (de la Brousse et al., 1994) , Stat3, Stat4, Stat6 (Transduction Laboratories), Elf-1, Sp1, Stat5a, Stat5b, Stat5 C17 which recognizes both Stat5a and Stat5b (Santa Cruz Biotechnology), as indicated in Figure legends . DNA binding proteins were isolated from whole cell extracts as described (Beadling et al., 1994) . For coimmunoprecipitation, 1 ml of whole cell extracts (10 7 cells) were incubated 1 h at 48C with 5 ml of antiserum. Immune complexes were precipitated with protein A-Sepharose (Pharmacia) as described (Kahn-Perles et al., 1997) . For GST-pull down assays, 1 ml whole cell extracts (10 7 cells) were incubated 2 h at 48C with GST-recombinant proteins as shown in Figure 3 legend coupled to glutathione sepharose 4B resin (Pharmacia), followed by three washes with 0.1% NP-40 lysis buer. For immunoblot analysis, after separation by SDS ± PAGE and transfer to PVDF membranes, proteins were detected with various antisera: Stat5b-speci®c antiserum (R&D Systems), anti-c-Rel polyclonal serum (Kahn-Perles et al., 1997), anti-Ets-1 (#41), -Ets-2 (#38) or -Ets-1/2 (#8).
Plasmids and mutagenesis
Wild-type or mutants pTK4-CAT/(GASd/EBSd)63 plasmids were constructed by multimerizing three copies of the following oligonucleotidic sequences containing the GASd/ EBSd element from the human IL-2Ra gene and cloning into the SacI and HindIII sites in the minimal promoter reporter gene vector pTK4-CAT (Lecine et al., 1996) : TCTTCTAG-GAAGTAT for wild-type GASd/EBSd (36G/E), TCTTCTCCGAAGTAT for mutant EBSd (36G/mE), TCGGCTAGGAAGTAT for mutant GASd (36mG/E) and TCGGCTCCGAAGTAT for double mutant GASd/EBSd (36mG/mE) (GAS motif is underlined and EBS motif is doubly underlined; substituted nucleotides are in boldface). The choice for the mutations was based on previous studies in which either factor binding or functional activity of the particular binding site was destroyed Wasylyk et al., 1993) . Wild-type or mutants pTK4-CAT/ (EBS)65 plasmids were constructed by multimerizing ®ve copies of the following oligonucleotidic sequences containing functional or mutated EBS element (Sieweke et al., 1998) and cloning into the SacI and HindIII sites in the minimal promoter reporter gene vector pTK4-CAT: TCGAGCAG-GAAGTTTCG for wild-type EBS (56EBS), TCGAGC- Figure 8 Two steps model of IL-2-induced Stat5-Ets interaction in T lymphocytes. IL-2 induces formation of a complex associating Stat5, Ets-1 and Ets-2 proteins in absence of their cognate DNA binding sites. This complex then binds to GASrelated regulatory elements. The requirement of a third partner (X), related or not to Stat5 and Ets families, cannot be excluded ACCAAGTTTCG for mutant EBS (56mEBS) (EBS motif is doubly underlined and substituted nucleotides for its disruption are in boldface). Expression vectors for mStat5b (pXM/Stat5b), Ets-1 and Ets-2 were previously described (Boulukos et al., 1989; Gegonne et al., 1993; Liu et al., 1995) . The GST-Ets constructs were kindly provided by M Sieweke and used in GST-pull down assays as described (Sieweke et al., 1996) .
Transient transfections and CAT assays
IL-2-starved Kit225 cells (1. 5610 7 ) were electrotransfected in a BioRad Gene Pulser (330 V, 960 mFD) with 20 mg of wild type or mutant pTK4-CAT/(GASd/EBSd)63 constructs. Amounts of expression vector used in transfections are indicated in Figure legends . Following transfection, cells were either maintained for 12 ± 16 h in RPMI 1650 10% FCS without IL-2 or with 20 nM IL-2, PMA (20 ng/ml) and ionomycin (1 mg/ml). Cell lysis and chloramphenicol acetyltransferase (CAT) assays were performed with the CAT enzyme-linked immunosorbent assay kit (Boehringer Mannheim) according to the manufacturer's instructions with 50 mg of cell extracts.
